Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube CarcinomaBevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma
Transcribed comments from recent interviews with Robert A Burger, MD (6/16/10), Robert L Coleman, MD (6/21/10), Thomas J Herzog, MD (6/21/10), Ursula A Matulonis, MD (6/16/10) and David R Spriggs, MD (6/23/10) about a presentation at ASCO 2010
Burger RA et al. Phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal or fallopian tube cancer: A Gynecologic Oncology Group (GOG) study. Proc ASCO 2010;Abstract LBA1. |